FDA applicant
Diagnostica Stago, Inc.
FDA records 25 decisions for Diagnostica Stago, Inc. (Parisppany, NJ) from 2001 to 2026: 25 510(k) clearances. Most are in product codes JPA (System, Multipurpose For In Vitro Coagulation…) and GGN (Plasma, Coagulation Control). Its devices cite 28 predicates, 12 of them its own earlier devices. 12 recalls are linked to its devices.
FDA’s records also spell it “Diagnostica Stago S.A.S”, “Diagnostica Stago”, “Diagnostica Stago, Incorporated”, “Diagnostica-Stago”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Diagnostica Stago, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
2in 2026
Class I Class II/III not classified
Planning a device like Diagnostica Stago, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Diagnostica”
FDA records each applicant name separately; these may or may not be the same firm.